E
H. F. Koolman et al.
Letter
Synlett
When applying the previously optimized reaction con-
ditions, it became apparent that the system would require
some direct irradiation as the use of a Pyrex® filter in com-
bination with the absorbing solvent acetone did not yield
any significant conversion (Table 3, entry 1).27 Limiting the
optical filter to very short wavelengths only (Table 3, entry
2, quartz) increased the conversion to 20%. Using toluene as
solvent resulted in higher conversion after a short irradia-
tion (Table 3, entry 3). However, the formation of decompo-
sition products and subsequent staining of the reactor
membrane28 led to an isolated yield of only 50%. To some
extent this could be minimized by applying a Vycor® filter
(Table 3, entry 4) where an isolated yield of 42% of the de-
sired spirocycle 17a could be obtained on a 0.9 mmol scale.
Using the latter conditions for the cyclization of the fluoro-
substituted derivatives 16b and 16c on even larger scale ei-
ther employing toluene or acetone as solvent enabled the
synthesis of these valuable building blocks, however, isolat-
ed yields were modest (16–23%, Table 3, entries 5–7).
In summary, we have demonstrated that 4,4′-disubsti-
tuted tetrahydroquinolines as part of diazepino-annelated
heterocycles can be synthesized efficiently by applying a
photochemical [6π]-acrylanilide cyclization in a meso- and
microfluidic photoreactor, even on multigram scale.
The highlighted synthetic route was suitable to synthesize
(±)-trans-vabicaserin for the first time. It tolerates substitu-
ents on the aromatic, as well as the acrylic moiety. In this
context, the 4-spirosubstituted dihydroquinoline moiety is
synthesized for the first time via a photocyclization. At-
tempts to transfer the method to the cyclization of a sim-
pler spiro-substituted acrylanilide precursor were essen-
tially successful, but performing those reactions on a larger
scale would require further optimization.
References and Notes
(1) (a) Sridharan, V.; Suryavanshi, P. A.; Menendez, J. C. Chem. Rev.
2011, 111, 7157. (b) Katritzky, A. R.; Rachwal, S.; Rachwal, B.
Tetrahedron 1996, 52, 15031. (c) Nammalwar, B.; Bunce, R. A.
Molecules 2014, 19, 204.
(2) Ferrari, M. L. A.; Coelho, P. M. Z.; Antunes, C. M. F. Tavares C. A.
P.; da Cunha, A. S. Bull. W.H.O. 2003, 81, 190.
(3) Imanishi, S.; Kimura, T.; Arita, M. Cardiovasc. Drug Rev. 1991, 9,
223.
(4) For recent relevant examples, see: (a) Chu, D. T. W.; Chen, J.;
Zhang, W.; Li, X.; Song, J.; Wang, B.; Cong, Q.; James, D. R. US
20060128790, 2006; Chem. Abstr. 2006, 145, 62795
(b) Frackenpohl, J.; Bojack, G.; Helmke, H.; Lehr, S.; Mueller, T.;
Willms, L.; Dietrich, H.; Schmutzler, D.; Baltz, R.; Bickers, U. WO
2015155154, 2015; Chem. Abstr. 2015, 163, 628222 (c) Feng, L.;
Huang, M.; Liu, Y.; Wu, G.; Yan, S.; Yun, H.; Zhou, M. US
20120190677, 2012; Chem. Abstr. 2012, 157, 294945
(5) Fauber, B. P.; Gobbi, A.; Savy, P.; Burton, B.; Deng, Y.; Everett, C.;
La, H.; Johnson, A. R.; Lockey, P.; Norman, M.; Wong, H. Bioorg.
Med. Chem. Lett. 2015, 25, 4109.
(6) Homan, K. T.; Larimore, K. M.; Elkins, J. M.; Szklarz, M.; Knapp,
S.; Tesmer, J. J. G. ACS Chem. Biol. 2015, 10, 310.
(7) Parmenon, C.; Guillard, J.; Caignard, D.-H.; Hennuyer, N.; Staels,
B.; Audinot-Bouchez, V.; Boutin, J.-A.; Ktorza, A.; Dacquet, C.;
Viaud-Massuard, M.-C. Bioorg. Med. Chem. Lett. 2008, 18, 1617.
(8) Venier, O.; Pascal, C.; Braun, A.; Namane, C.; Mougenot, P.;
Crespin, O.; Pacquet, F.; Mougenot, C.; Monseau, C.; Onofri, B.;
Dadji-Faïhun, R.; Leger, C.; Ben-Hassine, M.; Van-Pham, T.;
Ragot, J. L.; Philippo, C.; Güssregen, S.; Engel, C.; Farjot, G.; Noah,
L.; Maniani, K.; Nicolaï, E. Bioorg. Med. Chem. Lett. 2011, 21,
2244.
(9) Dunlop, J.; Watts, S. W.; Barrett, J. E.; Coupet, J.; Harrison, B.;
Mazandarani, H.; Nawoschik, S.; Pangalos, M. N.; Ramamoorthy,
S.; Schechter, L.; Smith, D.; Stack, G.; Zhang, J.; Zhang, G.;
Rosenzweig-Lipson, S. J. Pharm. Exp. Tech. 2011, 337, 673.
(10) (a) Megati, S.; Bhansali, S.; Dehnhardt, C.; Deshmukh, S.; Fung,
P.; Macewan, M.; Tinder, R. J. WO 2009039362, 2009; Chem.
Abstr. 2009, 150, 329853 (b) Dragan, V.; McWilliams, J. C.;
Miller, R.; Sutherland, K.; Dillon, J. L.; O'Brien, M. K. Org. Lett.
2013, 15, 2942. (c) Dziechciejewski, W. J.; Weber, R.; Sowada,
O.; Boysen, M. M. K. Org. Lett. 2015, 17, 4132.
Acknowledgment
The authors thank Tanja Lindner for supporting chemical synthesis.
Rickie S. Yarbrough, David N. Whittern, and Claudia Krack are ac-
knowledged for analytical support. Frank L. Wagenaar and Anita K.
McGreal are acknowledged for supporting purifications and Dave
Blanchard for engineering troubleshooting on the LOPHTOR system.
James Stambuli and Amanda W. Dombrowski are acknowledged for
useful comments regarding this manuscript. All are employees of
AbbVie. This study was sponsored by AbbVie. AbbVie contributed to
the study design, research, and interpretation of data, writing, re-
viewing, and approving the manuscript.
(11) It is noteworthy, that the commonly employed approach, a Pd-
catalyzed amidation of aryl halides, should allow the synthesis
of dihydroquinolinones bearing a quarternary center in the 4-
position if a suitable precursor is employed. Until now, this has
not been shown. For the underlying chemistry, see: (a) Zhang,
L.; Qureshi, Z.; Sonaglia, L.; Lautens, M. Angew. Chem. Int. Ed.
2014, 53, 13850. For the synthesis of such precursors, the pur-
posive Rh-based conjugate addition of ortho-halo-arylboronic
acids onto β-substituted acrylamides, however, fails even if only
a tertiary center is attempted, as stated in: (b) Zhang, L.;
Sonaglia, L.; Stacey, J.; Lautens, M. Org. Lett. 2013, 15, 2128; and
references cited therein.
(12) Parmenon, C.; Guillard, J.; Caignard, D.-H.; Hennuyer, N.; Staels,
B.; Audinot-Bouchez, V.; Boutin, J.-A.; Dacquet, C.; Ktorza, A.;
Viaud-Massuard, M.-C. Bioorg. Med. Chem. Lett. 2008, 18, 1617.
(13) Bunce, R. A.; Cain, N. R.; Cooper, J. G. Org. Prep. Proced. Int. 2013,
45, 28.
Supporting Information
Supporting information for this article is available online at
S
u
p
p
ortioInfgrmoaitn
S
u
p
p
ortiInfogrmoaitn
(14) (a) Pereira, J.; Barlier, M.; Guillou, C. Org. Lett. 2007, 9, 3101.
(b) Koolman, H. F.; Braje, W. M.; Mack, H.; Haupt, A.; Relo, A. L.;
Drescher, K.; Bakker, M. H. M.; Lakics, V.; Hoft, C.; Xu, R.; Zhao,
X. WO 2014041131, 2014; Chem. Abstr. 2014, 160, 457941
© Georg Thieme Verlag Stuttgart · New York — Synlett 2016, 27, A–F